Literature DB >> 20807097

Monomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders.

Francesca Montanari, Govind Bhagat, Sean Clark-Garvey, Venkatraman Seshan, Jasmine Zain, Catherine Diefenbach, Erin McCormick, Meaghan Crook, Meghan Conroy, Owen A O'Connor.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20807097     DOI： 10.3109/10428194.2010.500436

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  2 in total

Review 1.  Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder.

Authors:  Ajay Major; Manali Kamdar
Journal:  Curr Treat Options Oncol       Date:  2018-05-24

2.  Durable Response to Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, and Prednisone (BV-CHP) in a Patient with CD30-Positive PTCL Arising as a Post-Transplant Lymphoproliferative Disorder (PTLD).

Authors:  Jennifer Hong; William T Johnson; Saritha Kartan; Anitha S Gonsalves; Jonathan M Fenkel; Jerald Z Gong; Pierluigi Porcu
Journal:  Curr Oncol       Date:  2021-12-02       Impact factor: 3.677
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.